RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • SGLT2 inhibitors as add-on therapy to metformin for people with type 2 diabetes: a review of placebo-controlled trials in asian versus non-asian patients

SGLT2 inhibitors as add-on therapy to metformin for people with type 2 diabetes: a review of placebo-controlled trials in asian versus non-asian patients

Add to Collection
RCTs AJ Scheen - Diabetes, metabolic syndrome and obesity: targets …, 2020 - ncbi.nlm.nih.gov

Chapter : Section1, Section4, Section5
Journal Year : 2020
Cited by : 22

… SGLT2i empagliflozin compared with the DPP-4i sitagliptin as monotherapy, a trial that mainly … in India, was noninferior to dapagliflozin when added to metformin in Indian patients with …..... Read More

Keywords : ['asian versus nonasian patient', 'type diabetes', 'placebocontrolle trial', 'addon therapy', 'review', 'people', 'metformin', 'inhibitor']
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417649/
Google Scholar Link : https://scholar.google.com/scholar?cites=2951467450692165693&as_sdt=5,50&sciodt=0,50&hl=en&num=20